Skip to content
Clinical Trials for Alzheimer's Disease

Houston, Texas

Alzheimer's disease clinical trials in Houston, TX

14 Alzheimer's disease studies are recruiting participants at sites in Houston as of November 16, 2026, according to ClinicalTrials.gov. Clinical Trials for Alzheimer's Disease can help you understand your options and connect with a study team.

Call (888) 927-5895
  • No cost to ask
  • Taking part is voluntary
  • Studies are independently reviewed

Houston at a glance

  • 14 studies are recruiting at a site in Houston.
  • By phase: Phase 1/2 (2), Phase 2 (2), Phase 2/3 (1), Phase 3 (4), No phase (2), Observational (3). Studies of devices and behavioral approaches have no phase.
  • By sponsor: industry (8), university, hospital or other (6).
  • Most recent update to one of these records: November 12, 2026.

Studies recruiting in Houston

Basic details from each study's public record. Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.

  1. Open-Label Extension Study to Assess the Long-Term Safety and Tolerability of KarXT in Subjects With Psychosis Associated With Alzheimer's Disease (ADEPT-3)

    • Phase 3
    • Ages 55 to 90
    • All sexes
    Sponsor
    Karuna Therapeutics, Inc., a Bristol Myers Squibb company
    Study site
    Clinical Trial Network - 7080 Southwest Fwy
    Registry record
    NCT05980949 · updated
  2. Interleukine-2 (IL-2) Plus Semaglutide in Alzheimer's Disease

    • Phase 1/2
    • Ages 50 to 86
    • All sexes
    Sponsor
    The Methodist Hospital Research Institute
    Study site
    Houston Methodist Research Institute
    Registry record
    NCT07651319 · updated
  3. ACP-204 in Adults With Alzheimer's Disease Psychosis

    • Phase 2/3
    • Ages 55 to 95
    • All sexes
    Sponsor
    ACADIA Pharmaceuticals Inc.
    Study sites
    Clinical Trial Network LLC · Kaleidoscope Clinical Research · Prolato Clinical Research Center-Patton
    Registry record
    NCT06159673 · updated
  4. A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)

    • Phase 2
    • Ages 55 to 85
    • All sexes
    Sponsor
    Eli Lilly and Company
    Study sites
    Houston Methodist Hospital · The University of Texas Health Science Center at Houston
    Registry record
    NCT07589595 · updated
  5. A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).

    • Phase 3
    • Ages 55 and older
    • All sexes
    Sponsor
    Eli Lilly and Company
    Study site
    The University of Texas Health Science Center at Houston
    Registry record
    NCT07602582 · updated
  6. NON-INVASIVE BRAIN STIMULATION FOR MEMORY LOSS IN EARLY ALZHEIMER'S DISEASE

    • No phase
    • Ages 55 to 90
    • All sexes
    Sponsor
    Chi-Ying (Roy) Lin
    Study site
    Baylor College of Medicine
    Registry record
    NCT07667478 · updated
  7. A Study to Assess Efficacy and Safety of KarXT for the Treatment of Psychosis Associated With Alzheimer's Disease (ADEPT-1)

    • Phase 3
    • Ages 55 to 90
    • All sexes
    Sponsor
    Karuna Therapeutics, Inc., a Bristol Myers Squibb company
    Study site
    Clinical Trial Network - 7080 Southwest Fwy
    Registry record
    NCT05511363 · updated
  8. Epidemiology and Biomarker Study in Alzheimer's Disease

    • Phase 3
    • Ages 55 to 75
    • All sexes
    Sponsor
    Eli Lilly and Company
    Study site
    Care Access - Houston
    Registry record
    NCT07142954 · updated
  9. Smartphone-based Cognitive Emotion Regulation Training for Unpaid Primary Caregivers of Persons With Alzheimer's Disease

    • No phase
    • Ages 18 and older
    • All sexes
    Sponsor
    Bryan Denny
    Study site
    Rice University
    Registry record
    NCT05949047 · updated
  10. Stem Cell Therapy for Early Alzheimer's Disease

    • Phase 1/2
    • Ages 60 to 80
    • All sexes
    Sponsor
    Paul E Schulz
    Study site
    The University of Texas Health Science Center at Houston (UTHealth)
    Registry record
    NCT06775964 · updated
  11. Development of a Database to Investigate Digital and Blood-Based Biomarkers and Their Relationship to Tau and Amyloid PET Imaging in Older Participants Who Are Cognitively Normal (CN), Have Mild Cognitive Impairment (MCI), or Have Mild-to-Moderate AD Dementia

    • Observational
    • Ages 60 to 90
    • All sexes
    Sponsor
    GAP Innovations, PBC
    Study site
    Re:Cognition Health
    Registry record
    NCT06584357 · updated
  12. Selective PET Imaging of Astrocytes and Microglia in Alzheimer's Disease

    • Observational
    • Ages 18 to 90
    • All sexes
    Sponsor
    The Methodist Hospital Research Institute
    Study site
    Houston Methodist Research Institute
    Registry record
    NCT05582200 · updated
  13. Phosphorylated Tau Levels in Donated Blood

    • Observational
    • All ages
    • All sexes
    Sponsor
    The University of Texas Health Science Center, Houston
    Study site
    University of Texas Health Science Center at Houston
    Registry record
    NCT07157839 · updated
  14. Open-label Extension Study in Participants With Early Alzheimer's Disease

    • Phase 2
    • Ages 50 to 85
    • All sexes
    Sponsor
    GlaxoSmithKline
    Study site
    GSK Investigational Site
    Registry record
    NCT07105709 · updated

Source: ClinicalTrials.gov. Data processed . See every Alzheimer's disease study recruiting in Houston, TX on ClinicalTrials.gov.

Ask about studies near Houston

Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.

How should we reach you?
Add a message or the best time to reach you (optional)

Please do not include detailed medical information.

Before you contact a study

More locations in Texas

About these listings

These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 16, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded.

Clinical Trials for Alzheimer's Disease does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.

Sources and further reading

Ask about a study

A coordinator will contact you. Asking does not commit you to anything.

Call (888) 927-5895

or send a short form

How should we reach you?

Call